- Home
- GCTK vs QNRX Comparison
GCTK vs QNRX Comparison
Compare GCTK & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTK
- QNRX
- Stock Information
- Founded
- GCTK 2001
- QNRX 2018
- Country
- GCTK United States
- QNRX United States
- Employees
- GCTK N/A
- QNRX N/A
- Industry
- GCTK Medical/Dental Instruments
- QNRX Medical/Dental Instruments
- Sector
- GCTK Health Care
- QNRX Health Care
- Exchange
- GCTK Nasdaq
- QNRX Nasdaq
- Market Cap
- GCTK 4.1M
- QNRX 3.3M
- IPO Year
- GCTK N/A
- QNRX N/A
- Fundamental
- Price
- GCTK $6.59
- QNRX $9.60
- Analyst Decision
- GCTK
- QNRX
- Analyst Count
- GCTK 0
- QNRX 0
- Target Price
- GCTK N/A
- QNRX N/A
- AVG Volume (30 Days)
- GCTK 1.6M
- QNRX 12.9K
- Earning Date
- GCTK 08-12-2025
- QNRX 08-07-2025
- Dividend Yield
- GCTK N/A
- QNRX N/A
- EPS Growth
- GCTK N/A
- QNRX N/A
- EPS
- GCTK N/A
- QNRX N/A
- Revenue
- GCTK N/A
- QNRX N/A
- Revenue This Year
- GCTK N/A
- QNRX N/A
- Revenue Next Year
- GCTK N/A
- QNRX N/A
- P/E Ratio
- GCTK N/A
- QNRX N/A
- Revenue Growth
- GCTK N/A
- QNRX N/A
- 52 Week Low
- GCTK $5.16
- QNRX $5.01
- 52 Week High
- GCTK $3,756.00
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- GCTK 35.94
- QNRX 64.78
- Support Level
- GCTK $5.94
- QNRX $8.04
- Resistance Level
- GCTK $15.90
- QNRX $8.58
- Average True Range (ATR)
- GCTK 1.57
- QNRX 0.46
- MACD
- GCTK -0.01
- QNRX 0.04
- Stochastic Oscillator
- GCTK 0.56
- QNRX 98.57
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.